{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:02:05Z","timestamp":1791662525313,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jocn.2024.03.030","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T11:38:20Z","timestamp":1712057900000},"page":"123-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["TNF-\u03b1: A serological marker for evaluating the severity of hippocampal sclerosis in medial temporal lobe epilepsy?"],"prefix":"10.1016","volume":"123","author":[{"given":"Bingbing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwei","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2024.03.030_b0005","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.nec.2020.02.001","article-title":"Networks in Temporal Lobe Epilepsy","volume":"31","author":"Gonzalez","year":"2020","journal-title":"Neurosurg Clin N Am"},{"key":"10.1016\/j.jocn.2024.03.030_b0010","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1056\/NEJMra022308","article-title":"Epilepsy","volume":"349","author":"Chang","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2024.03.030_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2015.11.011","article-title":"Circulating CD4 and CD8 T cells expressing pro-inflammatory cytokines in a cohort of mesial temporal lobe epilepsy patients with hippocampal sclerosis","volume":"120","author":"Rosa","year":"2016","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.jocn.2024.03.030_b0020","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00415-017-8441-z","article-title":"Medial temporal lobe epilepsy associated with hippocampal sclerosis is a distinctive syndrome","volume":"264","author":"No","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2024.03.030_b0025","doi-asserted-by":"crossref","first-page":"6766","DOI":"10.2174\/1381612811319380009","article-title":"Inflammatory mediators in epilepsy","volume":"19","author":"Lorigados","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jocn.2024.03.030_b0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.neubiorev.2016.02.007","article-title":"Inflammatory mediators in human epilepsy: A systematic review and meta-analysis","volume":"63","author":"de Vries","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.jocn.2024.03.030_b0035","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.nbd.2015.07.003","article-title":"GABAA currents are decreased by IL-1beta in epileptogenic tissue of patients with temporal lobe epilepsy: implications for ictogenesis","volume":"82","author":"Roseti","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jocn.2024.03.030_b0040","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.7150\/ijbs.4679","article-title":"Interleukin-6, a major cytokine in the central nervous system","volume":"8","author":"Erta","year":"2012","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jocn.2024.03.030_b0045","article-title":"Pathological Targets for Treating Temporal Lobe Epilepsy: Discoveries From Microscale to Macroscale","volume":"12","author":"You","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.jocn.2024.03.030_b0050","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1007\/s12035-022-02725-6","article-title":"Neuroinflammation and Proinflammatory Cytokines in Epileptogenesis","volume":"59","author":"Soltani","year":"2022","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.jocn.2024.03.030_b0055","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1515\/revneuro-2017-0092","article-title":"Gliotransmitters and cytokines in the control of blood-brain barrier permeability","volume":"29","author":"Osipova","year":"2018","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.jocn.2024.03.030_b0060","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1080\/17474124.2018.1503053","article-title":"Advances in understanding the role of cytokines in inflammatory bowel disease","volume":"12","author":"Bevivino","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jocn.2024.03.030_b0065","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.eplepsyres.2016.08.012","article-title":"Clinical and electrophysiological findings in mesial temporal lobe epilepsy with hippocampal sclerosis, based on the recent histopathological classifications","volume":"127","author":"Tezer","year":"2016","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.jocn.2024.03.030_b0070","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/nan.12458","article-title":"Review: Neurodegenerative processes in temporal lobe epilepsy with hippocampal sclerosis: Clinical, pathological and neuroimaging evidence","volume":"44","author":"Tai","year":"2018","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.jocn.2024.03.030_b0075","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/epi.16509","article-title":"Interactions between in vivo neuronal-glial markers, side of hippocampal sclerosis, and pharmacoresponse in temporal lobe epilepsy","volume":"61","author":"Pimentel-Silva","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.jocn.2024.03.030_b0080","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00234-021-02704-z","article-title":"Usefulness of magnetic resonance spectroscopy in mesial temporal sclerosis: a systematic review","volume":"63","author":"Fernandez-Vega","year":"2021","journal-title":"Neuroradiology"},{"key":"10.1016\/j.jocn.2024.03.030_b0085","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.seizure.2008.01.008","article-title":"(1)H-MRS profile in MRI positive- versus MRI negative patients with temporal lobe epilepsy","volume":"17","author":"Doelken","year":"2008","journal-title":"Seizure"},{"key":"10.1016\/j.jocn.2024.03.030_b0090","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/nbm.1222","article-title":"Non-invasive detection of hippocampal sclerosis: correlation between metabolite alterations detected by (1)H-MRS and neuropathology","volume":"21","author":"Hammen","year":"2008","journal-title":"NMR Biomed"},{"issue":"Suppl 4","key":"10.1016\/j.jocn.2024.03.030_b0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1528-1167.2012.03610.x","article-title":"Hippocampal sclerosis\u2013origins and imaging","volume":"53","author":"Malmgren","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.jocn.2024.03.030_b0100","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2012.04.004","article-title":"The role of inflammation in epileptogenesis","volume":"69","author":"Vezzani","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jocn.2024.03.030_b0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nri.2016.123","article-title":"Cytokine networks in neuroinflammation","volume":"17","author":"Becher","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jocn.2024.03.030_b0110","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12974-021-02262-4","article-title":"Brain profiling in murine colitis and human epilepsy reveals neutrophils and TNFalpha as mediators of neuronal hyperexcitability","volume":"18","author":"Barnes","year":"2021","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jocn.2024.03.030_b0115","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12974-021-02265-1","article-title":"IL-1beta and HMGB1 are anti-neurogenic to endogenous neural stem cells in the sclerotic epileptic human hippocampus","volume":"18","author":"Zaben","year":"2021","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jocn.2024.03.030_b0120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bbi.2015.11.016","article-title":"Peripheral leukocyte profile in people with temporal lobe epilepsy reflects the associated proinflammatory state","volume":"53","author":"Vieira","year":"2016","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jocn.2024.03.030_b0125","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1684\/epd.2020.1155","article-title":"HMGB-1, TLR4, IL-1R1, TNF-alpha, and IL-1beta: novel epilepsy markers?","volume":"22","author":"Kamasak","year":"2020","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.jocn.2024.03.030_b0130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.eplepsyres.2017.11.017","article-title":"Whole brain neuronal abnormalities in focal epilepsy quantified with proton MR spectroscopy","volume":"139","author":"Kirov","year":"2018","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.jocn.2024.03.030_b0135","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.neuroscience.2014.07.030","article-title":"Role of blood-brain barrier in temporal lobe epilepsy and pharmacoresistance","volume":"277","author":"van Vliet","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.jocn.2024.03.030_b0140","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nbd.2013.11.019","article-title":"Longitudinal assessment of blood-brain barrier leakage during epileptogenesis in rats","volume":"63","author":"van Vliet","year":"2014","journal-title":"A quantitative MRI study Neurobiol Dis"},{"key":"10.1016\/j.jocn.2024.03.030_b0145","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/1535759719844750","article-title":"The roof is leaking and a storm is raging: repairing the blood-brain barrier in the fight against epilepsy","volume":"19","author":"Gorter","year":"2019","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.jocn.2024.03.030_b0150","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/164_2020_406","article-title":"Epilepsy and alterations of the blood-brain barrier: cause or consequence of epileptic seizures or both?","volume":"273","author":"Loscher","year":"2022","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.jocn.2024.03.030_b0155","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/ijp.ijp_253_21","article-title":"Antiepileptic-drug tapering and seizure recurrence: Correlation with serum drug levels and biomarkers in persons with epilepsy","volume":"54","author":"Sarangi","year":"2022","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.jocn.2024.03.030_b0160","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"Chen","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jocn.2024.03.030_b0165","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/j.sult.2007.11.005","article-title":"Hippocampal sclerosis: histopathology substrate and magnetic resonance imaging","volume":"29","author":"Bote","year":"2008","journal-title":"Semin Ultrasound CT MR"},{"key":"10.1016\/j.jocn.2024.03.030_b0170","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1528-1167.2008.01916.x","article-title":"Complex time-dependent alterations in the brain expression of different drug efflux transporter genes after status epilepticus","volume":"50","author":"Kuteykin-Teplyakov","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.jocn.2024.03.030_b0175","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1046\/j.1460-9568.2000.00140.x","article-title":"Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus","volume":"12","author":"De Simoni","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.jocn.2024.03.030_b0180","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.nbd.2004.03.010","article-title":"Innate immune reaction in response to seizures: implications for the neuropathology associated with epilepsy","volume":"16","author":"Turrin","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jocn.2024.03.030_b0185","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.expneurol.2013.01.011","article-title":"Opposing actions of hippocampus TNFalpha receptors on limbic seizure susceptibility","volume":"247","author":"Weinberg","year":"2013","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jocn.2024.03.030_b0190","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.779681","article-title":"Neuroprotective effect of otostegia limbata against PTZ-induced mice model of epilepsy by attenuated expression of p-NFkappaB and TNF-alpha","volume":"16","author":"Amin","year":"2022","journal-title":"Front Neurosci"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586824001322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586824001322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T04:42:08Z","timestamp":1749357728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586824001322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":38,"alternative-id":["S0967586824001322"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2024.03.030","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TNF-\u03b1: A serological marker for evaluating the severity of hippocampal sclerosis in medial temporal lobe epilepsy?","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2024.03.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}